Drug Description in Trials / DrugBank / KEGG DRUG /


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-y1] butanamide----1件: 309
2(2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide----1件: 309
3Brivaracetam1件: Brivaracetam1件: D08879 1件: SV2A 💬1件: ECM-receptor interaction 💬2件: 149, 309
4Brivaracetam 25 mg1件: Brivaracetam1件: D08879 1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 309
5Brivaracetam 50 mg1件: Brivaracetam1件: D08879 1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 309
6BRV 2.5 mg----1件: 309
7BRV 25 mg----1件: 309
8BRV 50 mg----1件: 309
9Intravenous Immunoglobulin----7件: 13, 14, 35, 38, 39, 51, 309
10REQUIP1件: Ropinirole1件: D08489 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 309
11ROPINIROLE1件: Ropinirole1件: D08489 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 74, 309
12Ropinirole Hydrochloride1件: Ropinirole1件: D08489 3件: DRD2,
DRD3,
DRD4 💬
8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬2件: 6, 309
13Ucb 34714----2件: 149, 309